Hennink W - Search Results

1

Conjugation of ovalbumin to trimethyl chitosan improves immunogenicity of the antigen.

Slütter B, Soema PC, Ding Z, Verheul R, Hennink W, Jiskoot W. Slütter B, et al. Among authors: hennink w. J Control Release. 2010 Apr 19;143(2):207-14. doi: 10.1016/j.jconrel.2010.01.007. Epub 2010 Jan 13. J Control Release. 2010. PMID: 20074597

2

Effect of DNA topology on the transfection efficiency of poly((2-dimethylamino)ethyl methacrylate)-plasmid complexes.

Cherng JY, Schuurmans-Nieuwenbroek NM, Jiskoot W, Talsma H, Zuidam NJ, Hennink WE, Crommelin DJ. Cherng JY, et al. Among authors: hennink we. J Control Release. 1999 Aug 5;60(2-3):343-53. doi: 10.1016/s0168-3659(99)00089-9. J Control Release. 1999. PMID: 10425339

3

Sterilization of poly(dimethylamino) ethyl methacrylate-based gene transfer complexes.

Bos GW, Trullas-Jimeno A, Jiskoot W, Crommelin DJ, Hennink WE. Bos GW, et al. Among authors: hennink we. Int J Pharm. 2000 Dec 15;211(1-2):79-88. doi: 10.1016/s0378-5173(00)00593-7. Int J Pharm. 2000. PMID: 11137341

4

Protein instability in poly(lactic-co-glycolic acid) microparticles.

van de Weert M, Hennink WE, Jiskoot W. van de Weert M, et al. Among authors: hennink we. Pharm Res. 2000 Oct;17(10):1159-67. doi: 10.1023/a:1026498209874. Pharm Res. 2000. PMID: 11145219 Review.

5

Release of recombinant human interleukin-2 from dextran-based hydrogels.

Cadée JA, de Groot CJ, Jiskoot W, den Otter W, Hennink WE. Cadée JA, et al. Among authors: hennink we. J Control Release. 2002 Jan 17;78(1-3):1-13. doi: 10.1016/s0168-3659(01)00483-7. J Control Release. 2002. PMID: 11772444

6

Restored functional immunogenicity of purified meningococcal PorA by incorporation into liposomes.

Arigita C, Kersten GF, Hazendonk T, Hennink WE, Crommelin DJ, Jiskoot W. Arigita C, et al. Among authors: hennink we. Vaccine. 2003 Feb 14;21(9-10):950-60. doi: 10.1016/s0264-410x(02)00546-7. Vaccine. 2003. PMID: 12547608

7

Nanotechnological approaches for the delivery of macromolecules.

Crommelin DJ, Storm G, Jiskoot W, Stenekes R, Mastrobattista E, Hennink WE. Crommelin DJ, et al. Among authors: hennink we. J Control Release. 2003 Feb 21;87(1-3):81-8. doi: 10.1016/s0168-3659(03)00014-2. J Control Release. 2003. PMID: 12618025 Review.

8

Liposomal meningococcal B vaccination: role of dendritic cell targeting in the development of a protective immune response.

Arigita C, Bevaart L, Everse LA, Koning GA, Hennink WE, Crommelin DJ, van de Winkel JG, van Vugt MJ, Kersten GF, Jiskoot W. Arigita C, et al. Among authors: hennink we. Infect Immun. 2003 Sep;71(9):5210-8. doi: 10.1128/IAI.71.9.5210-5218.2003. Infect Immun. 2003. PMID: 12933866 Free PMC article.

9

Shifting paradigms: biopharmaceuticals versus low molecular weight drugs.

Crommelin DJ, Storm G, Verrijk R, de Leede L, Jiskoot W, Hennink WE. Crommelin DJ, et al. Among authors: hennink we. Int J Pharm. 2003 Nov 6;266(1-2):3-16. doi: 10.1016/s0378-5173(03)00376-4. Int J Pharm. 2003. PMID: 14559389 Review.

10

Physicochemical and immunochemical techniques predict the quality of diphtheria toxoid vaccines.

Metz B, Jiskoot W, Hennink WE, Crommelin DJ, Kersten GF. Metz B, et al. Among authors: hennink we. Vaccine. 2003 Dec 12;22(2):156-67. doi: 10.1016/j.vaccine.2003.08.003. Vaccine. 2003. PMID: 14615142

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

570 results

Search Page

Filters